Literature DB >> 6689566

[Hyperparathyroidism after radioactive iodine therapy for Graves' disease: a case report].

J Kawamura, K Tobisu, S Sanada, Y Okada, O Yoshida, S Minami, M Hino, T Shigeno, J Konishi, R Morita.   

Abstract

Herein we report a 36-year-old man with hyperparathyroidism and a past history of internal irradiation to the thyroid. Twelve years previously at age 24 years he had received 8 mCi of radioactive iodine for Graves' disease. An additional dose of 4 mCi was required 3 years later. A right lower parathyroid adenoma (28 X 23 X 20 mm, 5.7 g) was found at neck exploration. Although the association of external ionizing radiation to the head and neck and the subsequent development of hyperfunctioning parathyroid glands has been described in recent years, there are only 4 cases in the literature of parathyroid surgery for hyperparathyroidism secondary to earlier treatment with radioactive iodine for Graves' disease. In a long-term follow-up of 180 patients treated with radioactive iodine for Graves' disease, neither hypercalcemia nor hypophosphatemia was found. Whether internal radiation therapy can be a causative factor in the development of hyperparathyroidism should be elucidated in future. However, it seems reasonable to suggest that patients whose hyperthyroidism has been treated with radioactive iodine should have their serum calcium levels examined at 5-year intervals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6689566

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  2 in total

1.  Parathyroid adenoma in patients with Graves' disease: a report of 21 cases.

Authors:  Shuanzeng Wei; Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

2.  Parathyroid Changes After RAI in Patients With Differentiated Thyroid Carcinoma.

Authors:  Liu Xiao; Wenjie Zhang; Hongmei Zhu; Yueqi Wang; Bin Liu; Rui Huang; Lin Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.